✨ Free AI Report
Fresenius Medical Care AG & Co. KGaA: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Fresenius Medical Care AG & Co. KGaA
Company Research

Fresenius Medical Care AG & Co. KGaA: Business Overview, Financials & Competitive Analysis

Fresenius Medical Care is the world's leading provider of products and services for individuals with renal disease. The company treats approximately 300,000 patients across nearly 3,700 clinics worldwide and accounts ...

Analyst-debate audio for Fresenius Medical Care AG & Co. KGaA

AskCyborg analysts argue the bull and bear cases for Fresenius Medical Care AG & Co. KGaA across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

Differentiated integrated dialysis leader with accelerating margins, transformation savings, and attractive capital allocation...

Read the full analyst-debate transcript →
Industry Healthcare Providers and Services - Dialysis and Renal Care
4 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Fresenius Medical Care AG & Co. KGaA Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Fresenius Medical Care AG & Co. KGaA Overview

Pro stress-test →

Fresenius Medical Care is the world's leading provider of products and services for individuals with renal disease. The company treats approximately 300,000 patients across nearly 3,700 clinics worldwide and accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. The company operates through a dual-segment model combining clinical dialysis services with medical technology manufacturing.

Strategic Profile

Pro stress-test →

The company reported strong organic revenue growth of 10% in Q3 2025, with operating income growth accelerating to 28% and operating income margin expanding to 11.7%. The FME25+ transformation program is delivering sustainable cost savings, with EUR 174 million delivered in the first nine months of 2025 toward a full-year target of EUR 180 million, with cumulative savings expected to reach EUR 1,050 million by year-end 2027. The company has committed to returning excess capital to shareholders through an initial EUR 1 billion share buyback program commenced in August.

Competitive Landscape

Pro stress-test →

Fresenius Medical Care is the largest dialysis provider globally and accounts for approximately 35% of the global dialysis products market. The competitive landscape includes other major dialysis providers and medical device manufacturers. Services account for about three-fourths of sales, while medical technology products enabling dialysis treatments generate the balance.

Industry Context

Fresenius Medical Care AG & Co. KGaA operates in Healthcare Providers and Services - Dialysis and Renal Care.

Key facts

Founded: 1996 · Headquarters: Bad Homburg, Germany · Employees: 112,035 · Revenue: $21.95B · Market cap: $13.15B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Fresenius Medical Care AG & Co. KGaA.

  • Q3 2025 delivered 10% organic revenue growth with 28% operating income growth and expanding 11.7% operating margins
  • Company operates as the largest dialysis provider globally with significant market share in dialysis products
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • January 2026Charles Hugh-Jones appointed as Global Chief Medical Officer effective January 1, 2026
  • November 2025Q3 2025 results showed 10% organic revenue growth with 28% operating income growth
  • +2 moreTrack every material event for Fresenius Medical Care AG & Co. KGaA as it happens. Explore monitoring →
Get alerted when Fresenius Medical Care AG & Co. KGaA has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Fresenius Medical Care AG & Co. KGaA with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Fresenius Medical Care AG & Co. KGaA operates in Healthcare Providers and Services - Dialysis and Renal Care. See how the rest of the sector scores on the Cyborg framework.

Browse Healthcare Providers and Services - Dialysis and Renal Care research →
NEW · MCP server

Ask your AI assistant about Fresenius Medical Care AG & Co. KGaA

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Fresenius Medical Care AG & Co. KGaA and its top competitor on Cyborg Score”
“What did Fresenius Medical Care AG & Co. KGaA do this quarter?”
“Is Fresenius Medical Care AG & Co. KGaA a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Fresenius Medical Care AG & Co. KGaA do?+
Fresenius Medical Care is the world's leading provider of products and services for individuals with renal disease. The company treats approximately 300,000 patients across nearly 3,700 clinics worldwide and accounts ...
What is Fresenius Medical Care AG & Co. KGaA's Cyborg Score?+
Fresenius Medical Care AG & Co. KGaA has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Fresenius Medical Care AG & Co. KGaA's main competitors?+
Named competitors include DaVita, Baxter, B. Braun, Outset Medical. The full competitive landscape is in the AskCyborg report.
How can I get the full Fresenius Medical Care AG & Co. KGaA research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Fresenius Medical Care AG & Co. KGaA research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Fresenius Medical Care AG & Co. KGaA over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual